Ultra-Long-Acting β2-Adrenoceptor Agonists: An Emerging Therapeutic Option for Asthma and COPD?

MG Matera, M Cazzola - Drugs, 2007 - Springer
There has been a real interest recently in developing once-daily β2-adrenoceptor agonists
(ultra-long-acting β 2-adrenoceptor agonists [ultra-LABAs]) for treating asthma and chronic …

Ultra-Long-Acting β2-Adrenoceptor Agonists: An Emerging Therapeutic Option for Asthma and COPD?

MG Matera, M Cazzola - Drugs, 2007 - search.ebscohost.com
There has been a real interest recently in developing once-daily β2-adrenoceptor agonists
(ultra-long-acting β2-adrenoceptor agonists [ultra-LABAs]) for treating asthma and chronic …

ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?

MG Matera, M Cazzola - Drugs, 2007 - europepmc.org
There has been a real interest recently in developing once-daily beta (2)-adrenoceptor
agonists (ultra-long-acting beta (2)-adrenoceptor agonists [ultra-LABAs]) for treating asthma …

Ultra-long-acting [[beta]. sub. 2]-adrenoceptor agonists an emerging therapeutic option for asthma and COPD?

MG Matera, M Cazzola - Drugs, 2007 - go.gale.com
There has been a real interest recently in developing once-daily [[beta]. sub. 2]-
adrenoceptor agonists (ultra-long-acting [[beta]. sub. 2]-adrenoceptor agonists [ultra-LABAs]) …

ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?

MG Matera, M Cazzola - Drugs, 2007 - pubmed.ncbi.nlm.nih.gov
There has been a real interest recently in developing once-daily beta (2)-adrenoceptor
agonists (ultra-long-acting beta (2)-adrenoceptor agonists [ultra-LABAs]) for treating asthma …

[引用][C] Ultra-long-acting β2-adrenoceptor agonists: An emerging therapeutic option for asthma and COPD?

MG MATERA, M CAZZOLA - Drugs (Basel), 2007 - pascal-francis.inist.fr
Ultra-long-acting β2-adrenoceptor agonists : An emerging therapeutic option for asthma and
COPD? CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

[PDF][PDF] Ultra-Long-Acting β2-Adrenoceptor Agonists

MG Matera, M Cazzola - Drugs, 2007 - researchgate.net
Abstract noceptor agonists (ultra-long-acting β2-adrenoceptor agonists [ultra-LABAs]) for
treating asthma and chronic obstructive pulmonary disease (COPD) in an attempt to simplify …

[引用][C] Ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?

MG Matera, M Cazzola - DRUGS, 2007 - iris.unicampania.it
Ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and
COPD? IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …

Ultra-long-acting beta (2)-adrenoceptor agonists-An emerging therapeutic option for asthma and COPD?

M Matera, M Cazzola - DRUGS, 2007 - art.torvergata.it
There has been a real interest recently in developing once-daily beta (2)-adrenoceptor
agonists (ultra-long-acting beta (2)-adrenoceptor agonists [ultra-LABAs]) for treating asthma …

Ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?

MG Matera, M Cazzola - Drugs, 2007 - search.ebscohost.com
There has been a real interest recently in developing once-daily beta (2)-adrenoceptor
agonists (ultra-long-acting beta (2)-adrenoceptor agonists [ultra-LABAs]) for treating asthma …